Sfoglia per AUTORE
RECK M
Collezione AOU San Luigi di Orbassano

  

Items : 31

HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI. in Future oncology (London, England) / Future Oncol. 2024 May;20(15):969-980. doi: 10.2217/fon-2023-0602. Epub 2023 Dec 14.
2024
AOU San Luigi di Orbassano

Meng J; Sternberg DW; Fougeray R; Fan PD; Wu YL; Steuer C; Reck M; Novello S; Nishio M; Jänne PA; Mok T; Esker S; Yu HA;

SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Jan 20;42(3):324-335. doi: 10.1200/JCO.23.01363. Epub 2023 Nov 17.
2024
AOU San Luigi di Orbassano

Tam SH; Ozawa Y; Novello S; Navarro A; Johnson M; Ozyilkan O; Chiu CH; Rittmeyer A; Dumoulin DW; Bryl M; Lee JS; Hong MH; Lu S; Soo RA; Liu SV; Rudin CM; Patil NS; Wen X; Huang M; Hoang T; Meng R; Reck M;

2023
AOU San Luigi di Orbassano

Zhou C; Srivastava MK; Xu H; Felip E; Wakelee H; Altorki N; Reck M; Liersch R; Kryzhanivska A; Oizumi S; Tanaka H; Hamm J; McCune SL; Bennett E; Gitlitz B; McNally V; Ballinger M; McCleland M; Zou W; Das Thakur M; Novello S;

Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2023 May;179:107173. doi: 10.1016/j.lungcan.2023.03.009. Epub 2023 Mar 15.
2023
AOU San Luigi di Orbassano

Reck M; Popat S; Grohé C; Corral J; Novello S; Gottfried M; Brueckl W; Radonjic D; Kaiser R; Heymach J;

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Jul;169:94-101. doi: 10.1016/j.lungcan.2022.05.009. Epub 2022 May 19.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Dingemans AC; von der Thüsen J; Remon J; Reguart N; O'Brien M; Reck M; Novello S; Mauer M; Lantuejoul S; Hendriks L; Greillier L; Girard N; Faivre-Finn C; Edwards J; De Ruysscher D; Brandão M; Bironzo P; Berghmans T; Giaj Levra M; Sperduti I; Menis J; Pilotto S; Avancini A; Milella M; Besse B;

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5.
2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano

Scagliotti GV; Caffo O; Irtelli L; Wiest G; Monica V; Porcu L; Manegold C; Dickgreber NJ; Bearz A; Pedrazzoli P; Follador A; Folprecht G; Griesinger F; Schmid-Bindert G; Reck M; Morabito A; Santo A; Gregorc V; Chiari R; Schena M; Borra G; Valmadre G; Ceribelli A; Kropf-Sanchen C; Stoelben E; Geissler M; Colantonio I; Cauchi C; Ladage D; et alii...

2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano

Manegold C; Scagliotti GV; Torri V; Grohe C; Porcu L; Follador A; Monica V; Wiest G; Irtelli L; Dickgreber NJ; Bearz A; Caffo O; Pedrazzoli P; Chiari R; Reck M; Schmid-Bindert G; Folprecht G; Griesinger F; Gregorc V; Santo A; Stoelben E; Ceribelli A; Serke M; Morabito A; Schena M; Valmadre G; Borra G; Kropf-Sanchen C; Colantonio I; et alii...

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042. in JTO clinical and research reports / JTO Clin Res Rep. 2021 Jul 1;2(8):100205. doi: 10.1016/j.jtocrr.2021.100205. eCollection 2021 Aug.
2021
AOU San Luigi di Orbassano

Mansfield AS; Herbst RS; de Castro G Jr; Hui R; Peled N; Kim DW; Novello S; Satouchi M; Wu YL; Garon EB; Reck M; Robinson AG; Samkari A; Piperdi B; Ebiana V; Lin J; Mok TSK;

2021
AO Cuneo
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Scagliotti G; Porcu L; Arizio F; Spatafora M; Righi L; Torri V; Wiest GH; Sotoparra H; Schumann C; Valmadre G; Borra G; Schena M; Morabito A; Santo A; Chiari R; Gregorc V; Reck M; Manegold C; Griesinger F; Follador A; Ferrari A; Bearz A; Caffo O; Irtelli L; Dickgreber N; Cecere F; Schutte W; Stoelben E; Geissler M; et alii...

RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis. in Cancer treatment and research communications / Cancer Treat Res Commun. 2021;27:100378. doi: 10.1016/j.ctarc.2021.100378. Epub 2021 Apr 19.
2021
AOU San Luigi di Orbassano

Frimodt-Moller B; Zimmermann AH; Fabre E; Alonso Garcia M; Moro-Sibilot D; Nadal E; Nakagawa K; Garon EB; Novello S; Ponce Aix S; Visseren-Grul CM; Reck M;

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9.
2020
AOU San Luigi di Orbassano

Novello S; Rubio-Viqueira B; Garon EB; Reck M; Jennens RR; Grossi F; Peled N; Bischoff HG; Cheng SY; Powell SF; Clingan P; Hochmair MJ; Hui R; Dómine M; Felip E; Esteban E; Speranza G; Gadgeel S; Rodríguez-Abreu D; Boyer M; Kurata T; Gray JE; Yang J; Bas T; Pietanza MC; Garassino MC;

Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jun;144:76-84. doi: 10.1016/j.lungcan.2020.04.009. Epub 2020 Apr 20.
2020
AOU San Luigi di Orbassano

Radonjic D; Gottfried M; Novello S; Reck M; Corral J; Grohé C; Popat S; Kaiser R;

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2020 Jun;15(6):914-947. doi: 10.1016/j.jtho.2020.03.006. Epub 2020 Mar 14.
2020
AOU San Luigi di Orbassano

Skoulidis F; Schalper KA; Popat S; Paz-Ares L; Mezquita L; Lu S; Kubota K; Horn L; Herbst RS; Goldberg SB; Gettinger S; Forde PM; Garon EB; Barlesi F; Ahn MJ; Passiglia F; Remon J; Reck M; Adjei AA; Scagliotti GV;

2020
AOU San Luigi di Orbassano

Lee P; Wolff K; Alexandris E; Oton AB; Zimmermann AH; Orlov SV; Cuyun Carter G; Brustugun OT; Gans S; Kim JH; Kalofonos H; Iglesias Docampo L; Thomas M; Reck M; Gautschi O; Scagliotti GV; Garon EB; Stefaniak VJ; Socinski MA; Pérol M;

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Oct;136:145-147. doi: 10.1016/j.lungcan.2019.08.007. Epub 2019 Aug 13.
2019
AOU San Luigi di Orbassano

Reck M; Berghmans T; Hasan B; Novello S; Dingemans AC; Besse B; Falk S; Le Péchoux C; Hendriks LEL; Levy A; Faivre-Finn C;

Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ?1% by the USA Food and Drug Administration. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Nov 1;30(11):1686-1688. doi: 10.1093/annonc/mdz295.
2019
AOU San Luigi di Orbassano

Tan D; Rolfo C; Reck M; Pennell NA; Peled N; Liu SV; Dingemans AM; Cufer T; Califano R; Blais N; Novello S; Remon J; Mountzios G; Vansteenkiste J; West H; Besse B;

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Nov;122:109-114. doi: 10.1016/j.ejca.2019.09.012. Epub 2019 Oct 28.
2019
AOU San Luigi di Orbassano

Besse B; Novello S; O'Brien M; Reck M; Edwards J; Lantuéjoul S; Girard N; Greillier L; Pochesci A; Hasan B; GiajLevra N; GiajLevra M; Faivre-Finn C; Berghmans T; Hendriks LEL; Levy A; Dingemans AC;

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4.
2019
AOU San Luigi di Orbassano

Au KH; Moro-Sibilot D; Shih JY; Yoh K; Imamura F; Nadal E; Novello S; Park K; Chiu CH; Paz-Ares L; Ponce Aix S; Nishio M; Seto T; Garon EB; Nakagawa K; Enatsu S; Zimmermann A; Frimodt-Moller B; Visseren-Grul C; Reck M;

Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Dec;14(12):2109-2119. doi: 10.1016/j.jtho.2019.07.025. Epub 2019 Aug 6.
2019
AOU San Luigi di Orbassano

Peters S; Porta RR; Infante M; Dziadziuszko R; Gietema H; Cufer T; Ekman S; McDonald F; Paz-Ares L; Guckenberger M; Senan S; Scagliotti GV; Peled N; Gaga M; Lievens Y; Ramella S; Postmus PE; Van Schil P; Smit EF; Reck M; O'Brien M; Edwards J; Lantuéjoul S; Greillier L; Girard N; Giaj-Levra N; Giaj-Levra M; Faivre-Finn C; Hasan B; et alii...

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Sep;13(9):1248-1268. doi: 10.1016/j.jtho.2018.05.030. Epub 2018 Jun 6.
2018
AOU San Luigi di Orbassano

Rolfo C; Mack PC; Scagliotti GV; Baas P; Barlesi F; Bivona TG; Herbst RS; Mok TS; Peled N; Pirker R; Raez LE; Reck M; Riess JW; Sequist LV; Shepherd FA; Sholl LM; Tan DSW; Wakelee HA; Wistuba II; Wynes MW; Carbone DP; Hirsch FR; Gandara DR;

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.
2018
AOU San Luigi di Orbassano

Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. in The New England journal of medicine / N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.
2018
AOU San Luigi di Orbassano

Gandhi L; Rodríguez-Abreu D; Gadgeel S; Esteban E; Felip E; De Angelis F; Domine M; Clingan P; Hochmair MJ; Powell SF; Cheng SY; Bischoff HG; Peled N; Grossi F; Jennens RR; Reck M; Hui R; Garon EB; Boyer M; Rubio-Viqueira B; Novello S; Kurata T; Gray JE; Vida J; Wei Z; Yang J; Raftopoulos H; Pietanza MC; Garassino MC; et alii...

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2018 Apr;93:37-46. doi: 10.1016/j.ejca.2018.01.067. Epub 2018 Feb 21.
2018
AOU San Luigi di Orbassano

Levy A; Faivre-Finn C; Hasan B; De Maio E; Berghoff AS; Girard N; Greillier L; Lantuéjoul S; O'Brien M; Reck M; Dingemans AC; Novello S; Berghmans T; Besse B; Hendriks L;

The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613. in Clinical lung cancer / Clin Lung Cancer. 2017 Sep;18(5):583-588. doi: 10.1016/j.cllc.2017.02.005. Epub 2017 Mar 1.
2017
AOU San Luigi di Orbassano

Remon J; Menis J; Hasan B; Peric A; De Maio E; Novello S; Reck M; Berghmans T; Wasag B; Besse B; Dziadziuszko R;

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.
2016
AOU San Luigi di Orbassano

Novello S; Barlesi F; Califano R; Cufer T; Ekman S; Levra MG; Kerr K; Popat S; Reck M; Senan S; Simo GV; Vansteenkiste J; Peters S;

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Nov;25(11):2156-2162. doi: 10.1093/annonc/mdu384. Epub 2014 Aug 19.
2014
AOU San Luigi di Orbassano

Novello S; Besse B; Felip E; Barlesi F; Mazieres J; Zalcman G; von Pawel J; Reck M; Cappuzzo F; Ferry D; Carcereny E; Santoro A; Garcia-Ribas I; Scagliotti G; Soria JC;

2014
AOU San Luigi di Orbassano

Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;

2014
AOU San Luigi di Orbassano

Besse B; Adjei A; Baas P; Meldgaard P; Nicolson M; Paz-Ares L; Reck M; Smit EF; Syrigos K; Stahel R; Felip E; Peters S; Peters S; Kerr K; Vansteenkiste J; Eberhardt W; Edelman M; Mok T; O'Byrne K; Novello S; Bubendorf L; Marchetti A; Baas P; Reck M; Paz-Ares L; Meldgaard P; Adjei A; Nicolson M; Van Schil P; et alii...

2014
AOU San Luigi di Orbassano

Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; van Schil P; Veronesi G; Stahel R; Peters S; Felip E; Kerr K; Besse B; Eberhardt W; Edelman M; Mok T; O'Byrne K; Novello S; Bubendorf L; Marchetti A; Baas P; Reck M; Syrigos K; Paz-Ares L; Smit E; Meldgaard P; Adjei A; et alii...

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2010 Jun;68(3):420-6. doi: 10.1016/j.lungcan.2009.07.011. Epub 2009 Aug 18.
2010
AOU San Luigi di Orbassano

Scagliotti GV; Germonpré P; Bosquée L; Vansteenkiste J; Gervais R; Planchard D; Reck M; De Marinis F; Lee JS; Park K; Biesma B; Gans S; Ramlau R; Szczesna A; Makhson A; Manikhas G; Morgan B; Zhu Y; Chan KC; von Pawel J;

Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2010 Apr 10;28(11):1835-42. doi: 10.1200/JCO.2009.26.1321. Epub 2010 Mar 8.
2010
AOU San Luigi di Orbassano

Scagliotti G; Novello S; von Pawel J; Reck M; Pereira JR; Thomas M; Abrão Miziara JE; Balint B; De Marinis F; Keller A; Arén O; Csollak M; Albert I; Barrios CH; Grossi F; Krzakowski M; Cupit L; Cihon F; Dimatteo S; Hanna N;